Ductal Patency in Neonates With Respiratory Distress Syndrome: A Randomized Surfactant Trial

Mark Reller, Donald C. Buffkin, Michael A. Colasurdo, Mary J. Rice, Robert W. McDonald

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The purpose of this study was to evaluate in a controlled study the effect of exogenous surfactant on various manifestations of ductal patency. Premature infants with respiratory distress syndrome were randomized to receive surfactant (Survanta) (n=22) or air (n=14). In neonates receiving surfactant, there was a greater tendency for an audible murmur to develop (13 of 22 vs four of 14). In spite of this, the clinical use of indomethacin was similar for the two groups, 10 (45%) of 22 vs six (43%) of 14. Excluding neonates given indomethacin early, a comparable number of surfactant-treated neonates (9/17 [53%]) vs control neonates (6/12 [50%]) demonstrated spontaneous closure of the ductus within a physiologic time frame (on or before day 4). For the gestational ages studied, the beneficial effects of exogenous surfactant were not associated with either an increased risk for delayed closure of the ductus arteriosus or a greater incidence of indomethacin usage. Utilization of exogenous surfactant does not appear to have an adverse impact on ductal patency.

Original languageEnglish (US)
Pages (from-to)1017-1020
Number of pages4
JournalAmerican Journal of Diseases of Children
Volume145
Issue number9
DOIs
StatePublished - 1991

Fingerprint

Surface-Active Agents
Newborn Infant
Indomethacin
Newborn Respiratory Distress Syndrome
Ductus Arteriosus
Premature Infants
Gestational Age
Air
Incidence

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Ductal Patency in Neonates With Respiratory Distress Syndrome : A Randomized Surfactant Trial. / Reller, Mark; Buffkin, Donald C.; Colasurdo, Michael A.; Rice, Mary J.; McDonald, Robert W.

In: American Journal of Diseases of Children, Vol. 145, No. 9, 1991, p. 1017-1020.

Research output: Contribution to journalArticle

Reller, Mark ; Buffkin, Donald C. ; Colasurdo, Michael A. ; Rice, Mary J. ; McDonald, Robert W. / Ductal Patency in Neonates With Respiratory Distress Syndrome : A Randomized Surfactant Trial. In: American Journal of Diseases of Children. 1991 ; Vol. 145, No. 9. pp. 1017-1020.
@article{c83de1f7e4b745509ea16893d0b3a128,
title = "Ductal Patency in Neonates With Respiratory Distress Syndrome: A Randomized Surfactant Trial",
abstract = "The purpose of this study was to evaluate in a controlled study the effect of exogenous surfactant on various manifestations of ductal patency. Premature infants with respiratory distress syndrome were randomized to receive surfactant (Survanta) (n=22) or air (n=14). In neonates receiving surfactant, there was a greater tendency for an audible murmur to develop (13 of 22 vs four of 14). In spite of this, the clinical use of indomethacin was similar for the two groups, 10 (45{\%}) of 22 vs six (43{\%}) of 14. Excluding neonates given indomethacin early, a comparable number of surfactant-treated neonates (9/17 [53{\%}]) vs control neonates (6/12 [50{\%}]) demonstrated spontaneous closure of the ductus within a physiologic time frame (on or before day 4). For the gestational ages studied, the beneficial effects of exogenous surfactant were not associated with either an increased risk for delayed closure of the ductus arteriosus or a greater incidence of indomethacin usage. Utilization of exogenous surfactant does not appear to have an adverse impact on ductal patency.",
author = "Mark Reller and Buffkin, {Donald C.} and Colasurdo, {Michael A.} and Rice, {Mary J.} and McDonald, {Robert W.}",
year = "1991",
doi = "10.1001/archpedi.1991.02160090069025",
language = "English (US)",
volume = "145",
pages = "1017--1020",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Ductal Patency in Neonates With Respiratory Distress Syndrome

T2 - A Randomized Surfactant Trial

AU - Reller, Mark

AU - Buffkin, Donald C.

AU - Colasurdo, Michael A.

AU - Rice, Mary J.

AU - McDonald, Robert W.

PY - 1991

Y1 - 1991

N2 - The purpose of this study was to evaluate in a controlled study the effect of exogenous surfactant on various manifestations of ductal patency. Premature infants with respiratory distress syndrome were randomized to receive surfactant (Survanta) (n=22) or air (n=14). In neonates receiving surfactant, there was a greater tendency for an audible murmur to develop (13 of 22 vs four of 14). In spite of this, the clinical use of indomethacin was similar for the two groups, 10 (45%) of 22 vs six (43%) of 14. Excluding neonates given indomethacin early, a comparable number of surfactant-treated neonates (9/17 [53%]) vs control neonates (6/12 [50%]) demonstrated spontaneous closure of the ductus within a physiologic time frame (on or before day 4). For the gestational ages studied, the beneficial effects of exogenous surfactant were not associated with either an increased risk for delayed closure of the ductus arteriosus or a greater incidence of indomethacin usage. Utilization of exogenous surfactant does not appear to have an adverse impact on ductal patency.

AB - The purpose of this study was to evaluate in a controlled study the effect of exogenous surfactant on various manifestations of ductal patency. Premature infants with respiratory distress syndrome were randomized to receive surfactant (Survanta) (n=22) or air (n=14). In neonates receiving surfactant, there was a greater tendency for an audible murmur to develop (13 of 22 vs four of 14). In spite of this, the clinical use of indomethacin was similar for the two groups, 10 (45%) of 22 vs six (43%) of 14. Excluding neonates given indomethacin early, a comparable number of surfactant-treated neonates (9/17 [53%]) vs control neonates (6/12 [50%]) demonstrated spontaneous closure of the ductus within a physiologic time frame (on or before day 4). For the gestational ages studied, the beneficial effects of exogenous surfactant were not associated with either an increased risk for delayed closure of the ductus arteriosus or a greater incidence of indomethacin usage. Utilization of exogenous surfactant does not appear to have an adverse impact on ductal patency.

UR - http://www.scopus.com/inward/record.url?scp=0026093761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026093761&partnerID=8YFLogxK

U2 - 10.1001/archpedi.1991.02160090069025

DO - 10.1001/archpedi.1991.02160090069025

M3 - Article

C2 - 1877559

AN - SCOPUS:0026093761

VL - 145

SP - 1017

EP - 1020

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 9

ER -